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Protectionotective effect of live attenuated SIV vaccine strains have yielded variable results
depending on the route of immunization, the level of attenuation, the level of divergence between the
vaccine candidate and the challenge. The protective mechanisms induced by these vaccines are still not well
understood. In an effort to address whether the diversity of the CD4+ T cell repertoire in cynomolgus
macaques plays a role in the immunological protection following SIVmacC8 infection, we have performed a
longitudinal follow-up of the CD4 repertoire by heteroduplex tracking assay in macaques mock-infected or
infected with either the attenuated SIVmacC8 or its homologous SIVmacJ5 and challenged with simian-
human immunodeﬁciency virus (SHIV89.6P). Viral load and CD4 absolute counts were determined in these
animals and the presence of SHIV89.6P virus in challenged animals was evaluated by PCR and serology. In
all macaques that were protected against the challenging virus, we demonstrated a reduced diversity in the
CD4+ TRBV repertoire and a few dominant CD4+ T cell clones during early primary infection. In contrast, CD4
TRBV repertoire in unprotected macaques remained highly diverse. Moreover, some of the CD4 T cell clones
that were expanded during primary SIV infection re-emerged after challenge suggesting their role in
protection against the challenging virus. These results underline the importance of maintaining the CD4 T cell
repertoire developed during acute infection and point to the restriction of the CD4 response to the vaccine as
a correlate of protection.
© 2008 Elsevier Inc. All rights reserved.IntroductionImmunological responses generated against persistent viral infec-
tions are characterized by the activation and expansion of CD4 and
CD8 antigen-speciﬁc T lymphocytes. Although cytotoxic T cell
responses are responsible for clearance of most viral infections (Shin
andWherry, 2007; Purtha et al., 2007; Kuroda et al., 1999), CD4 T cells
play a major role in supporting antibody production, initiating and
maintaining CTL activity as well as performing direct effector activity
through the production of speciﬁc cytokines (Ribeiro, 2007; Daven-
port et al., 2007). Following viral suppression through immunological
control, these T cells decline in activity and number mostly through
apoptosis (McHeyzer-Williams and Davis, 1995; Gupta and Gollapudi,, Hôpital Saint-Luc, 264, René-
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l rights reserved.2007; Badovinac et al., 2002), leaving the host with a sufﬁcient
number of pathogen-speciﬁc memory T cells. The major role of
memory T cells is to ensure protection upon re-exposure to pathogens
through rapid clonal proliferation and functional activation. This has
been demonstrated in both CD8 (Walker et al., 1996; Levitsky et al.,
1998; Maryanski et al., 1996; Sourdive et al., 1998; Blattman et al.,
2000; Roberts and Woodland, 2004; Geginat et al., 2003) and CD4
positive T cells (Bitmansour et al., 2001; seder and Ahmed, 2003;
Sallusto et al., 2004; Zaph et al., 2004). Several factors including the
stimuli, the host or the environment can all contribute to create
variations between antigen-selected repertoires. These factors can
also inﬂuencewhether a potent antigen-speciﬁc repertoire is selected,
whether it is persistent and protective.
Attempts to generate a vaccine against human immunodeﬁciency
virus (HIV) have led to the evaluation of attenuated strains as can-
didates. Macaques challenged with pathogenic simian immunodeﬁ-
ciency virus (SIV) several months after being infected with live
attenuated SIV show better protection than monkeys immunized by
240 M.-D. Salha et al. / Virology 377 (2008) 239–247any other vaccine strategy (Tenner-Racz et al., 2004; Johnson et al.,
1999; Mori et al., 2001; Koff et al., 2006). The use of attenuated SIV
viruses as vaccines has provided complete or near complete protection
from challenge with wild type SIV (Koff et al., 2006). Better protection
was obtained with homologous challenge than with heterologous
challenge (Johnson and Desrosiers, 1998). The most common strategy
of attenuating SIV was achieved by the complete or partial deletion of
nef (SIVΔnef or SIVmacC8, respectively) or the deletion of both nef and
vpr (SIVΔ3). The use of these viruses has provided strong protection
against pathogenic SIV challenge (Johnson and Desrosiers, 1998).
Another way of attenuating SIV was achieved through the deletion of
V1–V2 region of the envelope protein (Env; SIVΔV1–V2). This virus has
also conferred potent protection from intravenous challenge by wild
type SIVmac239 (Cole et al., 2004).
The correlates and mechanisms of protection induced by attenu-
ated viruses, however, are poorly understood. Stebbings et al. de-
monstrated using CD8 T cells depletion techniques, that CD8 T cell
responses alone are not central to the protection against acute
superinfection conferred 20 days after vaccination with attenuated
SIVmacC8 (Stebbings et al., 2005). This conclusionwas consistent with
the ﬁndings of other investigators who were unable to identify a
correlation between SIV-speciﬁc CD8 CTL responses elicited by
inoculation with live attenuated SIV and protection against super-
infection (Sharpe et al., 2004; Dittmer et al., 1999).
The persistence of the CD4 helper function was shown in several
model systems to be essential for the maintenance of memory CD8
responses during chronic infection as well as the generation of
neutralizing antibodies to viral escape mutants and for the control of
viremia (Suvas et al., 2003; Sun et al., 2004; Sun and Bevan, 2003;
Matloubian et al., 1994; von Herrath et al., 1996; Zajac et al., 1998;
Wodarz and Jansen, 2001; Ahmed et al., 1988; Kalams et al., 1999).
While the rapid turnover of CD4 T cells characterize HIV/SIV infection,
it is not clear towhat extent HIV/SIV infections can drive an expansion
rather than a depletion of antigen-speciﬁc CD4 T cells. Assessing T cellFig. 1. Disease status in SIV-infected animals. CD4 absolute count (right panels) and plasma S
and C—mock-infected macaques. Animals infected with SIVmacJ5 or SIVmacC8 show slow
infected macaques show a rebound in viral load and a progressive drop in CD4 counts. SIV vi
strains were used to quantify SIV viral load. Results were quantiﬁed by comparison with pur
The detection limit of this assay was 1500 copies of SIVmac RNA per ml until week 35 and 50
were used to calculate the absolute CD4 counts.receptor (TCR) repertoire during HIV/SIV infection will add to our
understanding of the way T cells respond to this infection and
contribute in mediating protection. Chen et al. have shown using
CDR3 proﬁle and sequence analysis of CD4 T cell receptor repertoires
that infection of macaques with SIV can result in prolonged periods of
clonal dominance of CDR3-restricted CD4 T cell clones despite the
decline of CD4 T cell count (Chen et al., 2000).
In this study we evaluated the impact of the breadth and persis-
tence of CD4 Tcell repertoire stimulated during primary infectionwith
attenuated SIVmacC8 and pathogenic SIVmacJ5 strains on the
resistance to subsequent challenge with the highly pathogenic
simian-human immunodeﬁciency virus (SHIV89.6P) strain.
Results
Virological and immunological evolution following SIVmacJ5 or
SIVmacC8 infection
In order to analyze the relationship between the breadth of the
CD4 repertoire induced during primary infection (PI) by attenuated
SIV strains and the susceptibility to subsequent superinfection,
cynomolgus macaques were infected with either the pathogenic
SIVmac strain SIVmacJ5 or the attenuated strain SIVmacC8 (Cranage
et al., 1992). Twenty weeks post-primary infection, animals were
challenged with the pathogenic SHIV89.6P strain.
In all SIVmacJ5-infected macaques the CD4 count transiently
dropped 2 weeks post-infection and returned to normal values at
following time points (Fig. 1A). In these animals viral load peaked
simultaneously to the CD4 decline (~108 copies per ml) and settled at
week 6 below the limit of detection, with some occasional viral blips.
In the SIVmacC8-infected group, macaques C93054F and C94042F
had both lower CD4 counts at study entry compared to other
macaques in that group and did not show any signiﬁcant perturba-
tions in their CD4 counts during acute infection (Fig. 1B). Except for aIV RNA detected by branched DNA (left panels) from groups A—SIVmacJ5, B—SIVmacC8,
progressor patterns. Following challenge at week 20 with SHIV89.6P, two SIVmacC8-
ral load target probes, designed to hybridize with the pol region of the SIVmac groups of
iﬁed and quantiﬁed in vitro-transcribed SIV pol RNA and were plotted on a log(10) scale.
0 thereafter. White blood cell counts were obtained from a hematology workstation and
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macaque C94036F also remained stable during primary infection. The
CD4 count in macaque C94011M demonstrated major ﬂuctuations
during the primary-infection period. After an initial drop one-week
post-infection followed by a transient increase until week 4 post-
infection, the CD4 count in that animal returned to pre-infection value
by week 20 post-infection. All the SIVmacC8-infected macaques
showed a peak in viral load (5×105–8×106 copies per ml) at week 2
and the virus settled by week 6 below the limit of detection. Mock-
infected animals had variable CD4 counts from one time point to
another but remained between normal values during the follow-up
period (Fig. 1C).
Post-infection CD4+ TRBV repertoire evolves independent of the infecting
SIV strain
The diversity of the CD4 TRBV repertoire was evaluated using the
heteroduplex tracking assay (HTA) in two mock-infected macaques,
and four SIVmacC8- or SIVmacJ5-infected macaques, prior to infection
(week −3 and 0) until week 8 post-infection (week 1, 2, 4, 6 and 8).
Seven TRBV families were analyzed (TRBV9, 20, 28, 5-1, 7, 12 and 3). As
deﬁned in Fig. 2A, the CD4 TCR population for each analyzed TRBV
family was classiﬁed according to the number of detectable discrete
bands, TRBV families composed of 13 or more discrete bands wereFig. 2. TRBV5-1 CD4+ families in uninfected, SIVmacJ5- and SIVmacC8-infected
macaques. A. Computerized densitometric analysis of the HTA autoradiography. Each
band on the HTA gel is transformed into a peak using the NIH image software. Each
band represents a CD4 clonotype. An HTA proﬁle is highly diverse when it is compo-
sed of more than 13 clones and with low diversity when it is composed of or less than
12 clones. Arrows indicate discrete TRBV hetero-complexes over the HTA proﬁles.
B. Heteroduplex tracking assay using TRBV5-1 as 5′-primers and BC as 3′-primers was
performed on puriﬁed CD4+ T cells collected from − 3 weeks prior to SIV infection until
week 8 post-infection. Data from representative SIVmacJ5-, SIVmacC8-, and mock-
infected macaques is shown. SIVmacJ5 and SIVmacC8 include macaques with low and
high diversity CD4 repertoires, whereas uninfectedmacaques have always highly diverse
repertoires.considered as highly diverse repertoires while the TRBV families with
less than 13 bands were separated into 2 groups according to the
degree of diversity (i.e. low diversity (1–6 bands) or intermediate
diversity (7–12 bands)). A representative example (TRBV5-1) showing
the evolution of the TCR repertoires following SIVmacJ5- and
SIVmacC8-infected macaques as well as a mock-infected macaque is
shown in Fig. 2B. The overall diversity of the analyzed TRBV re-
pertoires varied both between animals and between samples from
each animal. Fig. 3 illustrates the longitudinal analysis of the CD4
repertoires in all the animals during PI. The SIVmacJ5-infected group
was comprised of macaques with mixed repertoires: 3/4 animals had
mainly low diversity TRBV families C94066F and C94055F and C95011F
(Figs. 2B and 3), whereas 1/4 in that group, C94073F, had both low and
high diversity TRBV families, such as TRBV20 and TRBV3 respectively.
As for the SIVmacC8 group, 2/4 macaques showed a very diverse TRBV
repertoire throughout the follow-up period (C93054F and C94042F)
and two others had mixed repertoires (C94036F and C94011M).
During the same period, a persistent highly diverse CD4 TRBV
repertoire characterized both mock-infected macaques tested.
The development of a low diversity CD4 TRBV repertoire during PI is
associated with resistance to challenge with SHIV89.6P
The animals were challenged with SHIV89.6P at week 20 post-
primary infection. Two macaques from the SIVmacC8-infected group
(C93054F and C94042F) demonstrated evidence of superinfection
(data not shown). Macaque C93054F showed a rebound in viral load at
week 26 (106 copies per ml) that remained high during the follow-up
period, whereas macaque C94042F had two expansions in viral load at
week 24 (106 copies per ml) and at week 31 (8×104 copies per ml).
None of the superinfected macaques experienced any decrease in CD4
counts as compared to their pre-challenge values, however the initial
CD4 counts were lower in these animals than in the protected
macaques from the same group. In the other 6 protected animals
neither viral load nor CD4 counts were signiﬁcantly modiﬁed follow-
ing challenge (Figs. 1A and B). The absence of detectable SHIV89.6P
infectionwas conﬁrmed by nested PCR ampliﬁcation of the SHIV89.6P
env gene (data not shown). The four mock-infected control animals
were susceptible to SHIV89.6P infection. All fourmacaqueswithin that
group showed a drastic drop in CD4 counts (below 200 cells per µl)
during the ﬁrst week post-challenge. While CD4 counts in 3/4 mock-
infected macaques remained very low, macaque C95024M showed a
transient rebound in CD4 count to normal values, however byweek 74
the CD4 count dropped again below 200 cells per µl (data not shown).
All the control animals experienced very high viral loads (107–109
copies per ml) at week 2 post-SHIV89.6P infection. Viral set point
was reached by week 24 to 35 and viral load remained between 104
and 107 copies per ml in all four animals up to the end of the study
(Fig. 1C).
Considering that, irrespective of the infecting virus, some
macaques were protected against SHIV89.6P challenge, we investi-
gated whether there was an association between protection against
SHIV89.6P superinfection and TCR repertoire diversity in the CD4+
compartment, either prior or during primary SIV infection.
Interestingly, all the animals with low diversity CD4 TRBV
repertoire following primary SIV infection were resistant to chal-
lenge, irrespective of the SIV strain used for primary infection.
Several TRBV families from protected animals had evolved overtime
following SIV infection, such as TRBV9 for macaques C94055F,
C94066F, C95011F as well as TRBV20 for macaques C94073F and
C94011M (see Fig. 3). These TRBV families progressed from a highly
diverse repertoire prior to infection to a very restricted repertoire
composed of less than 6 clones during PI. Other TRBV families were
either always restricted (such as TRBV28 for macaque C94055F) or
evolved further to include less CD4 clonotypes (such as TRBV28 and
TRBV5-1 for macaque C94066F).
Fig. 3. Summary of the longitudinal analysis of the CD4+ TRBV repertoire during primary SIV infection. The clonality of each TRBV family at each time point and for eachmacaquewas
determined during −3weeks prior to SIV infection until 8 weeks post-infection. Heteroduplex tracking assay using a panel of TRBV as 5′-primers that include (TRBV9, 20, 28, 5-1, 7,12,
and 3) and BC as 3′-primers was performed on puriﬁed CD4+ T cell clones from −3 weeks until week 8 post-infection. In order to simplify the representation of these results, black
boxes represent highly diverse repertoires containing 13 clones andmore, grey boxes represent intermediate diversity repertoires containing between 7 and 12 clones, whereas white
boxes represent low diversity repertoires with less than 6 clones. Boxes with a cross represent samples that were not done.
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infected macaques susceptible to challenge (C93054F and C94042F),
the TRBV repertoire was highly diverse prior to SIV infection and
remained highly diverse during the 8 weeks of follow-up (Fig. 3).
This longitudinal analysis of the CD4+ TRBV repertoires in animals
resistant to SHIV89.6P challenge suggests that the CD4+ T cell
proliferation induced during primary SIV infection in these animals
was restricted to a limited number of clones.
The low diversity repertoires developed during PI in protected animals
persist following challenge
In order to evaluate the possible role of CD4 Tcell clones stimulated
during primary infection in the resistance to the challenging virus, we
investigated whether some of these clones were 1) persisting during
PI and 2) reemerging following SHIV89.6P challenge.
In case of macaque C94066F, for-example, two co-migrating HTA
bands were observed at week 8 post-infection, and again at week 2
post-challenge (Fig. 4A). In order to investigate whether those co-
migrating bands truly belong to the same TCR clone, the PCR products
corresponding to TRBV5-1 ampliﬁcations in macaque C94066F were
cloned and 25, 30 or 22 clones were sequenced for time points 4 and
8 weeks post-SIVmacJ5 infection, and 2 weeks post-challenge
respectively. Two dominant clones (NRG and LGS) were identiﬁed at
high frequency at week 8 post-infection. Interestingly, among them
one CD4 clonotype (NRG) was also detected at week 2 post-challenge
(Fig. 4B). To certify that the co-migrating bands observed by HTA at
week 8 and week 2 post-challenge belong to clone (NRG), the PCR
products corresponding to TRBV5-1 at week 8 and plasmid DNAcorresponding to clones NRG, LGS and as a control LGQ were run next
to each other in an HTA gel. Fig. 4C indicates that the upper band in the
PCR sample of week 8 correspond to clone NRG, whereas the lower
band corresponds to clone LGS. These results demonstrated that co-
migrating bands can indeed correspond to TCRs with identical CDR3
regions. Therefore each HTA experiment showing co-migrating bands
were considered as belonging to the same T cell clone only when an
independent HTA experiment using series of other TRBV probes were
able to conﬁrm the co-migration.
We ﬁrst analyzed the persistence of expanded CD4+ T cell clones in
the SIVmacJ5-, SIVmacC8-infected and control animals during the ﬁrst
12 weeks of follow-up. Interestingly, almost all the protected animals,
whether they were infected by SIVmacJ5 or SIVmacC8 viruses, had at
least two TRBV families with persistent CD4 clonotypes during PI
(Table 1). In contrast, unprotected and mock-infected animals showed
little (C94042F in TRBV28) or no persistence of CD4 clonotypes during
PI. Although some TRBV families in unprotected or uninfected
macaques were composed of a few dominant clones at some time
points post-infection, these dominant clones did not persist (i.e.
TRBV5-1 for macaque C93054F) suggesting that in these animals, the
CD4+ T cells clonally expanded during primary infection were rapidly
lost during the followingweeks (Mattapallil et al., 2005; Li et al., 2005;
Picker and Watkins, 2005).
We then evaluated whether some of the expanded clones iden-
tiﬁed during primary infection could participate in the resistance to
superinfection by SHIV89.6P. We longitudinally analyzed the CD4+
TRBV repertoire during the ﬁrst four weeks following challenge and
compared the clonally expanded clones to those stimulated during
primary infection (Fig. 5). Following challenge, the CD4+ TRBV
Fig. 4. Analysis of the re-emergence of CD4 clonotypes in a protected animal. A— TRBV5-1+CD4+clonotypes inmacaque C94066Fwas analyzed by HTA fromweek −3 toweek 4 post-
challenge. Arrows represent co-migrating bands at week 8 andweek 2 post-challenge. B— The PCR products from time points 4, 8 and 22weeks (or 2 weeks post-challenge) as shown
by the arrows in Panel A, were cloned and sequenced to identify their CDR3 regions as described in Materials and methods. At week 8 two dominant CDR3 regions were identiﬁed,
NRGSF with 10/25 clones and LGSD with 9/25 clones. At week 2 post-challenge those two dominant TCR clones were detected. C— Co-migration of the DNA plasmids encoding the
two dominant clones detected at week 8, NRG and LGS together with the PCR product fromweek 8. These results demonstrate that clones co-migrating at the same level are identical.
243M.-D. Salha et al. / Virology 377 (2008) 239–247repertoires were either of high or low diversity in the different
macaques.
In protected macaques (Fig. 5A), many CD4+ T cell clones identiﬁed
during primary SIV infection persisted following challenge. In some
cases, such as TRBV5-1 for macaque C95011F, the repertoire was con-
stantly restricted throughout the study. In other cases, theCD4 repertoires
contractedovertimeand, byweek8,up to 6CD4clonotypeswerepresent
(for-example: TRBV9 for macaque C94055F, TRBV3 for macaque
C94055F). Following challenge at week 1 through 4, some clones that
were present during PI dominated the repertoire (Fig. 5A, arrows).
Occasionally the repertoire returned to high diversity following challenge
such as TRBV5-1 atweek 4 post-challenge inmacaque C94066F (Fig. 4A).
Interestingly, the unprotected as well as themock-infected animals
demonstrated CD4+ T cell clone expansions following challenge
(Fig. 5B). However, none of these expanded clones were detected
before challenge. At week 12 and contrary to the preceding samples, a
low diversity CD4+ repertoire was identiﬁed for TRBV20 in macaque
C94042F. However, these clones did not correspond to earlier CD4
clonotypes, nor did they persist at later time points, or re-expand afterTable 1
Clonotype persistence during PI
Macaque Virus Time points showing persistent clones during PI (weeks
TRBV9 TRBV9 TRBV9 TRBV20 TRBV28 TRBV5-1
C94055F SIVmacJ5 1, 4b
C94066F
C94073F 4, 6 1, 4
C95011F 4, 6 1, 4; 6, 8, 12
C94036F SIVmacC8 6, 8 4, 6
C94011M 4, 8 1, 2, 4
C94042F SIVmacC8 4, 6
C93054F
C94077M Uninfected
C95025F
a Two TRBV probes with different CDR3 and BJ regions were used to conﬁrm co-migratio
b Weeks after infection.
c Macaques in which no SHIV89.6P viral RNA can be detected by PCR, serology.
d Macaques in which SHIV89.6P viral RNA can be detected by PCR and serology.challenge. Following infection of control animals with SHIV89.6P, CD4
TRBV repertoires shifted to low diversity. However, at week 2, the CD4
counts in control animals dropped below 200 cells per µl, therefore
the contraction of the CD4 repertoires at that time point, which
includes very few clones, could represent the limited CD4 clones still
remaining in these animals (Fig. 5C).
Discussion
In this study we analyzed the breadth of the CD4 TRBV repertoire
during primary SIV infection in cynomolgus macaques and evaluated
its impact on the resistance to subsequent challenge. We determined
the dominance of CD4 T cell clones initiated during primary infection
with attenuated SIVmacC8 and pathogenic SIVmacJ5, and their
persistence following subsequent challenge with the highly patho-
genic SHIV89.6P strain. Our results indicated that the development of
CD4 clonotypes early following SIV infection and their maintenance
over time is associated with protection against subsequent challenge
with virulent SHIV89.6P.)a Status
TRBV7 TRBV12 TRBV3
4, 6 Resistant to SHIV89.6P challengec
4, 6 6, 8
Susceptible to SHIV89.6P challenged
n of bands.
Fig. 5. Evolution of the CD4+ TRBV repertoire in animals protected and unprotected from SHIV89.6P superinfection. Longitudinal analysis of the CD4 TCR repertoire prior to, following
SIV and SHIV89.6P challenge at week 20. Vertical lines delineates between pre-challenge and post-challenge time points. A— Animals resistant to SHIV89.6P superinfection (refer also
to Fig. 4A for animal C94066F, TRBV5-1). B— Animals susceptible to SHIV89.6P superinfection. C—Mock-infected animals infected with SHIV89.6P at week 20. Whereas animals
susceptible to SHIV89.6P superinfected have a highly diverse repertoire pre- and post-challenge, macaques resistant to superinfection have restricted repertoire post-challenge, and
some are composed of dominant CD4 clonotypes that have been generated pre-challenge during acute SIV infection.
244 M.-D. Salha et al. / Virology 377 (2008) 239–247Cynomolgus macaques infected with SIVmacJ5 or SIVmacC8 de-
veloped different types of CD4 T cell repertoires irrespective of the
infecting strain (Figs. 2 and 3). While some animals demonstrated a
very restricted diversity in all the studied TRBV families within a few
weeks post-infection, others showed a low diversity repertoire in onlysome TRBV families or even remained completely diverse. Such a
heterogeneous response was clearly neither due to the infecting
strain, nor was it a consequence of the intensity of the acute phase.
An interesting observation was the association between resistance
to superinfection by SHI89.6P and the contraction of some CD4 TRBV
245M.-D. Salha et al. / Virology 377 (2008) 239–247subsets followingpeak viremia to include ahandful of clones byweek 8
post-infection. Furthermore, upon challengewith SHIV89.6P, the same
clonotypes that were present during primary SIV infection became
dominant as early as one week post-challenge in some TRBV families.
These results suggest that immuno-surveillance against SIV infection
rests with few CD4 clonotypes recognizing a limited array of SIV
determinants. This further supports the idea that these CD4 clonotypes
were generated against SIV epitopes and were re-activated after
encountering SHIV89.6P, which shares several homologies with
SIVmac (Reimann et al., 1996; Karlsson et al., 1997). The sequential
association of these clonal cell populations with infection and the
dominance of these cell populations following challenge with
SHIV89.6P suggest that these cells are SIV-speciﬁc. Several studies
have shown that memory CD4 (Bitmansour et al., 2001) or CD8
(Levitsky et al., 1998; Maryanski et al., 1996; Sourdive et al., 1998;
Blattman et al., 2000) responses largely reﬂect the repertoire selected
by the peak of the primary response. Fasso et al. demonstrated that a
TCR repertoire selection process occurs early in the immune response
in vivo, resulting in a relatively homogenous population of CD4+ Tcells
(Fasso et al., 2000). Moreover, In their pigeon cytochrome c (PCC)
immunizationmodel, McHeyzer-Williams et al. demonstrated that the
secondary CD4+ T cell response to PCC was more homogeneous than
the primary response in terms of CDR3 loop length and amino acid
composition (McHeyzer-Williams and Davis, 1995; Heyzer-Williams
et al., 1996a;Heyzer-Williams et al., 1999; Heyzer-Williams et al.,
1996b). Through a maturation process, it is possible that the second
immune response has the ability at this stage to prevent the esta-
blishment of a second round of viral infection upon challenge, a
property that primary T cell responses do not have.
However, not all animals had a contraction of the TRBV repertoire
upon infection, in fact those animals already demonstrated a low
diversity repertoire atW-3 and/orW0 (TRBV5 in C94066F, TRBV28 and
TRBV5 in C94055F, TRBV5 in C94036F). In these cases it is possible that
the state of activation at the time of infection inﬂuenced the
subsequent repertoire diversity.
The most intriguing ﬁnding was the association between highly
diverse CD4 T cell repertoire during PI and susceptibility to super-
infection with SHIV89.6P. All the animals that developed a restricted
repertoire remained resistant to challengewith SHIV89.6P,while those
that had a highly diverse repertoire were susceptible (Fig. 3). The high
diversity of the CD4 T cell repertoire in unprotected animals following
challenge, suggests that the SIV-speciﬁc CD4 T cells stimulated during
PI were not able to survive or to clonally expand. This could be due to
the speciﬁc destruction of activated CD4 T cells during early primary
SIV infection as demonstrated in humans (Mattapallil et al., 2005). Our
results suggest that the ability to develop clonally expandedCD4 Tcells
during PI, a combination of both activation/proliferation of the CD4 T
cell clones and death/anergy/inhibition of proliferation due to viral
infection, is a major component of subsequent disease development or
resistance to superinfection.
However, SIVmacC8-infected macaques susceptible to SHIV89.6P
superinfection did not experience the same rate of disease progression
as did control animals following SHIV89.6P infection. This suggests
that in unprotected SIVmacC8-infected animals, other factors may be
involved in preventing a rapid disease progression, which is usually
caused by virulent strains such as SHIV89.6P. Following SHIV89.6P
infection, the pool of potentially infectable CD4 Tcells is less important
in SIVmacC8-infected animals than they are inmock-infected controls,
which would cause a higher SHIV89.6P replication potential in the
latter and as a consequence, a poor disease outcome. Moreover,
infection with SIVmacC8 may have induced CD8-speciﬁc responses
that might play a role in decreasing susceptibility to superinfection
compared to naïve animals. Although unprotected animals do not
succumb to disease as rapidlyasmock-infected controls, one of the two
unprotected macaques (C93054F) died by week 105 post-challenge
and the other C94042F had two peaks in viremia following challengeand showed a poor prognosis at later time points. Interestingly, while
the 12-bp deletion was maintained in macaque C94042F, the nef gene
in macaque C93054F experienced a recombination between the nef of
SHIV89.6P and SIVmacC8 (Rud et al. unpublished observations). This
recombination was due to superinfection and not a self repair of
SIVmacC8 as observed byWhatmore et al. (Whatmore et al., 1995) and
resulted in a repair of the 12-bp deletion which most likely led to the
rapid CD4 T cell loss.
The association between highly diverse CD4 T cell repertoires and
susceptibility to superinfection is contrasted to what was described in
the CD8 compartment by Price et al. (2004). While a polyclonal SIV-
speciﬁc CD8 T cell repertoire characterized by highly conserved CDR3
motifs was associated with mutation in the viral epitope, a diverse
CDR3 usage in the clonotypic population of SIV-speciﬁc CD8 response
was not associated with viral escape mutants. It is important to point
out that the major difference between CD4 and CD8 T cell responses is
the ﬁne balance between activation of functional SIV-speciﬁc CD4 T
cell clones and the expansion of putative SIV targets, which is only
observed in the CD4 compartment of SIV-infected animals. Therefore,
the association between highly diverse CD4 repertoires and super-
infection by SHIV89.6P, could be explained by the fact that these
animals have a larger pool of naïve CD4 T cells due to the lack of SIV-
speciﬁc CD4 responses that can be a target for SHIV89.6P. These
reservoirs can then facilitate even further SIV replication and
ultimately accelerating disease progression (Pierson et al., 2000).
Ideally, the narrowing of the CD4+ T cell repertoire following SIV
infection through the presence of few dominant SIV-speciﬁc CD4 Tcell
clones would minimize viral output and re-infection by having fewer
targets available. Altogether, the association between resistance to
superinfection with SHIV89.6P and the restriction and maturation of
CD4 TRBV repertoires in cynomolgus macaques following SIV
infection, underlines the importance of narrowing the CD4 TRBV
repertoire early in infection: First, to build the anti-viral immune
response against SIV, and second, to limit the pool of CD4 infectable
targets.
Materials and methods
Viruses
Viral isolates include: SIVmacJ5 and SIVmacC8 originating from
SIVmac32H(pJ5) and SIVmac32H(pC8) molecular clones respectively
and SHIV89.6P, a pathogenic chimeric SHIV (Reimann et al., 1996).
The molecular clones, SIVmac32H(pJ5) and SIVmac32H(pC8), were
isolated from cells infected with the 11/88 pool of SIVmac32H, an
isolate derived by in vivo passage of SIVmac251 in rhesus macaque
32H (Cranage et al., 1992). The attenuated SIVmacC8 virus clone
differs from the wild type SIVmacJ5 clone by a 12-bp deletion and
two non synonymous nucleotide changes, resulting in conservative
amino acid changes in the nef open reading frame (Rud et al., 1994).
In contrast to SIVmacJ5, which induces an AIDS-like pathology in
infected macaques, SIVmacC8 shows an attenuated phenotype in
monkeys (Cranage et al., 1992 and G. Hall, personal communication).
SHIV89.6P infection results in a rapid decline in CD4+ T cell counts in
rhesus and cynomolgus macaques within a couple of months of
infection (Reimann et al., 1996). The SIVmacJ5- and SIVmacC8-
infected animals along with a group of four naïve macaques (mock-
infected) were challenged with SHIV89.6P (a gift from Dr Keith
Reimann) at week 20.
Animals
Animals used in this study were part of a large European concerted
action on AIDS vaccine (Vogel et al., 1998) and Rud, unpublished data).
Three groups of four juvenile (approx. 3 year old) cynomolgus
macaques (Macaca fascicularis) (these cynomolgus macaques are
246 M.-D. Salha et al. / Virology 377 (2008) 239–247from a breeding colony derived from the Philippines in 1983 and not
the commercially available cynomolgus macaques from Mauritius)
were infected via the intravenous route. All animals used in this study
were colony bred within the Non-human Primate Breeding Colony of
Health Canada under Canadian Council of Animal Care approved
conditions. All animals were serologically negative for Herpes B virus,
STLV-1, SRV-1, 2, 5 and SIV (The Virus Reference Laboratory, Inc., San
Antonio, TX). The percentage of CD4-positive T lymphocytes was
determined using a FACScan® (Becton Dickinson, CA, USA) ﬂow
cytometer and CELLQuest software. Whole blood collected in EDTA
was analyzed for lymphocyte subsets by incubation with anti-human
CD2 (Fluorescein Isothiocyanate (FITC)-labeled, Becton Dickinson),
anti-human CD4 (Phycoerythrin (PE)-labeled, Becton Dickinson).
White blood cell countswere obtained from ahematologyworkstation
(Coulter Counter S-PLUS IV, FL, USA) and were used to calculate the
lymphocyte subset absolute counts.
Plasma viral load
Plasma SIV RNA concentrations were determined using a branched
DNA signal ampliﬁcation method developed by Dr. Peter Dailey
(Chiron Corporation, Emeryville, CA) for SIV using the same approach
as Quantiplex HIV RNA branched DNA method (Pachl et al., 1995). For
quantitating SIV viral load, target probes designed to hybridize with
the pol region of the SIVmac strains were used. In each sample, SIV
RNA concentration was quantiﬁed by comparisonwith puriﬁed and in
vitro-transcribed SIV pol RNA. The lower limit of detection of this assay
was 15,000 copies of SIVmac RNA per ml plasma in all the animals, at
the initiation of the study but was further improved to detect down to
500 copies at 35 weeks.
CD4 T cell puriﬁcation
Macaque PBMCs (10×106 cells) collected at described time points
were used to isolate CD4 T cells by staining with microbeads-
conjugated CD4 antibodies (Miltenyi Biotech) and subjecting them
to MACS MS columns and MACS magnetic cell sorting apparatus
(Miltenyi Biotech) as recommended by themanufacturer. Puriﬁed CD4
+ T cells were then washed in PBS and resuspended into Trizol® (Life
technologies, Burlington, Canada) for RNA extraction. CD4 T cell purity
(N90%) was veriﬁed for each sample by staining with PE-conjugated
anti-CD4 and PERCP-conjugated anti-CD8 antibodies (Becton Dick-
inson, CA, USA) and analyzed on a FACScan® using the Cell Quest®
Software.
Heteroduplex tracking assay
Heteroduplex tracking assays (HTA) were performed as described
(Shen et al., 1998) for all SIV-infected and two uninfected macaques in
this study at the bleeding time points (−3, 0,1, 2, 4, 6, 8,12,16, 20, 21, 22
and 24weeks post-infectionwith SIVmacJ5 or SIVmacC8). Brieﬂy, total
RNA was puriﬁed from CD4 T cells as mentioned above using Trizol®
andwas used to synthesize complementary DNA (cDNA) using oligo dT
(12–18) primers. Nested polymerase chain reaction (nPCR) was
performed on cDNA samples from sequential time points using
TRBVout and Cβout as outer primers and TRBVin and Cβin as inner
primers for TRBV9, 20, 28, 5-1, 7, 12, and 3 (Chen et al., 1993). These
TRBV families were chosen because they were found to be the most
dominant TRBV families in cynomolgus macaques after analysis of the
whole TCR repertoire in four healthy cynomolgus macaques using the
same nPCR strategy (data not shown). The uniformity of yield and
ampliﬁcation efﬁcacy of each primer pair was assessed by agarose gel
electrophoresis. In parallel, 32-P-labeled probes were produced by PCR
ampliﬁcation of two TRBV-Cβ inserts previously cloned in Bluescript
(Stratagene Cloning Systems, La Jolla, Ca), using 32-P-labeled Cβin
primer and unlabeled TRBVin primers. Radiolabeled DNA heterodu-plexes were obtained by mixing 4.5 μl from second round PCR
with 0.5 μl of probe in annealing buffer (0.16 M NaCl, 16 mM Tris
[pH 8.0], 3.3 mM EDTA). DNA was denatured at 95 °C for 2 min, after
which they were reannealed at 55 °C for 5 min and rapidly cooled to
room temperature in a thermocycler. Heteroduplexeswere resolved on
a 20-cm high, 5% polyacrylamide gel (29:1 acrylamide:bisacrylamide)
at 200 V for 3 h. HTA gels were vacuum-dried and a PhosphorImager
(Amersham Pharmacia Biotech, NJ, USA) plate was used for signal
detection. The clonality of each TRBV family in each sample was
analyzed using the NIH image software as shown in Fig. 2A. A TRBV
repertoire composed of 13 clones or more was considered as highly
diverse, whereas that of 12 clones or lesswas considered as not diverse
(restricted). Moreover, within restricted repertoires, we distinguished
between populations composed of less than 7 clones (low diversity)
and those containing 7 to 12 clones (intermediate diversity).
Molecular cloning and sequencing of the CDR3 regions
Ampliﬁcation products were cloned into Bluescript vector and
transformed into E. coli. (DH5α). Plasmids containing the cloned TCR
inserts were sequenced using T7 DNA polymerase (Amersham
Pharmacia Biotech, NJ, USA) or automated sequencing (Sheldon
Biotechnology Center, McGill University, Montreal).
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